From Vessels to Neurons-The Role of Hypoxia Pathway Proteins in Embryonic Neurogenesis

Cells. 2024 Apr 3;13(7):621. doi: 10.3390/cells13070621.

Abstract

Embryonic neurogenesis can be defined as a period of prenatal development during which divisions of neural stem and progenitor cells give rise to neurons. In the central nervous system of most mammals, including humans, the majority of neocortical neurogenesis occurs before birth. It is a highly spatiotemporally organized process whose perturbations lead to cortical malformations and dysfunctions underlying neurological and psychiatric pathologies, and in which oxygen availability plays a critical role. In case of deprived oxygen conditions, known as hypoxia, the hypoxia-inducible factor (HIF) signaling pathway is activated, resulting in the selective expression of a group of genes that regulate homeostatic adaptations, including cell differentiation and survival, metabolism and angiogenesis. While a physiological degree of hypoxia is essential for proper brain development, imbalanced oxygen levels can adversely affect this process, as observed in common obstetrical pathologies such as prematurity. This review comprehensively explores and discusses the current body of knowledge regarding the role of hypoxia and the HIF pathway in embryonic neurogenesis of the mammalian cortex. Additionally, it highlights existing gaps in our understanding, presents unanswered questions, and provides avenues for future research.

Keywords: HIF; NSC; embryonic neurogenesis; hypoxia; neocortex; neural progenitor cells; vascularization.

Publication types

  • Review

MeSH terms

  • Animals
  • Female
  • Humans
  • Hypoxia / metabolism
  • Mammals
  • Neural Stem Cells* / metabolism
  • Neurogenesis / genetics
  • Neurons / metabolism
  • Oxygen / metabolism
  • Pregnancy

Substances

  • Oxygen

Grants and funding

This work was funded by grants from the DFG (German Research Foundation) within the CRC/Transregio 205/1, Project no. 314061271-TRR205, ‘The Adrenal: Central Relay in Health and Disease’ (A02) to B.W.; DFG grants WI3291/14-1 to B.W. This work was also supported by a grant from the DFG priority program µBONE 2084 and a cancer research grant from the Wilhelm Sander foundation to B.W.; project no. 288034826.